Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Enzyme Inhibition and Medicinal Chemistry is Scopus-indexed (Q1, CiteScore 11.9), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1475-6366Verify ISSN ↗1475-6374Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 28 / 328 | 91st | Q1 |
| Drug Discovery | 15 / 161 | 90th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present (also 1998–1999, 1985–1996), best quartile Q1, CiteScore 11.9.
Journal of Enzyme Inhibition and Medicinal Chemistry is Q1 in Pharmacology (rank 28 of 328) and Q1 in Drug Discovery (rank 15 of 161), by CiteScore 2025.
Journal of Enzyme Inhibition and Medicinal Chemistry is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.9, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.776, quartile Q2, with an H-index of 103.
The publisher lists an article processing charge of about US$2,306 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Enzyme Inhibition and Medicinal Chemistry is published by Taylor and Francis Ltd. Its print ISSN is 1475-6366 and its online ISSN is 1475-6374.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Enzyme Inhibition and Medicinal Chemistry has an h-index of 108 and a 2-year mean of 3.87 citations per paper (OpenAlex). Its Scopus CiteScore is 11.9, quartile Q1. On 2-year citations it ranks #78 of 319 Scopus journals in Pharmacology.
Journal of Enzyme Inhibition and Medicinal Chemistry published 112 papers in 2025; its busiest recent year was 2022 with 207. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from China (59.2%), United States (7.1%) and South Korea (6.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 21 retracted papers are recorded (6 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.